ICUI vs. ATRI, MMSI, HAE, NARI, TNDM, NVCR, IART, IRTC, PRCT, and LMAT
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Atrion (ATRI), Merit Medical Systems (MMSI), Haemonetics (HAE), Inari Medical (NARI), Tandem Diabetes Care (TNDM), NovoCure (NVCR), Integra LifeSciences (IART), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), and LeMaitre Vascular (LMAT). These companies are all part of the "surgical & medical instruments" industry.
ICU Medical (NASDAQ:ICUI) and Atrion (NASDAQ:ATRI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.
Atrion has a net margin of 10.60% compared to ICU Medical's net margin of -2.63%. Atrion's return on equity of 7.75% beat ICU Medical's return on equity.
ICU Medical presently has a consensus price target of $123.00, suggesting a potential upside of 18.28%. Given ICU Medical's higher probable upside, equities analysts clearly believe ICU Medical is more favorable than Atrion.
In the previous week, Atrion had 2 more articles in the media than ICU Medical. MarketBeat recorded 5 mentions for Atrion and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.13 beat Atrion's score of 0.12 indicating that ICU Medical is being referred to more favorably in the media.
Atrion has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
ICU Medical received 254 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.48% of users gave ICU Medical an outperform vote while only 55.36% of users gave Atrion an outperform vote.
ICU Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Atrion has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 66.2% of Atrion shares are held by institutional investors. 6.7% of ICU Medical shares are held by insiders. Comparatively, 22.8% of Atrion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Atrion beats ICU Medical on 9 of the 17 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ICU Medical Competitors List
Related Companies and Tools
